Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026)
Compugen recorded quarterly Non-Current Deffered Revenue of $22.1 million in Q1 2026, down 11.24% quarter-over-quarter from $24.9 million in Q4 2025.
Compugen's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $22.1 million for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $22.1 million; the TTM figure through Mar 2026 stood at $22.1 million (changed N/A YoY), while the FY2025 annual figure was $24.9 million, down 26.74% from the prior year.
- Non-Current Deffered Revenue came in at $22.1 million for Q1 2026 at Compugen, down from $24.9 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $34.0 million in Q4 2024 to a low of $22.1 million in Q1 2026.
- A 4-year average of $26.6 million and a median of $25.2 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue surged 34.08% in 2024 and slipped 26.74% in 2025, its largest moves.
- Compugen's Non-Current Deffered Revenue stood at $25.4 million in 2023, then jumped by 34.08% to $34.0 million in 2024, then retreated by 26.74% to $24.9 million in 2025, then decreased by 11.24% to $22.1 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $22.1 million, $24.9 million, and $34.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 225.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 22.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.14 Mn |
| Dec 31, 2025 | 24.94 Mn |
| Sep 30, 2025 | 27.57 Mn |
| Jun 30, 2025 | 29.59 Mn |
| Mar 31, 2025 | 31.77 Mn |
| Dec 31, 2024 | 34.05 Mn |
| Sep 30, 2024 | 29.24 Mn |
| Jun 30, 2024 | 21.03 Mn |
| Mar 31, 2024 | 23.23 Mn |
| Dec 31, 2023 | 25.39 Mn |
| Dec 31, 2013 | 1.45 Mn |